# Cnicus benedictus **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/cnicus-benedictus **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-19 **Evidence Score:** 6 / 10 **Category:** European **Also Known As:** Cnicus benedictus, Blessed thistle, Holy thistle, St. Benedict's thistle, Spotted thistle, Carduus benedictus, Cnicus, Benedict's herb ## Overview Cnicus benedictus (blessed thistle) contains bioactive compounds including cnicin and flavonoids that may exhibit anticancer and analgesic properties. Preclinical studies suggest it works through nitric oxide pathway modulation and selective antiproliferative mechanisms. ## Health Benefits • May inhibit cancer cell growth - methanolic extract showed antiproliferative effects on HeLa cervical cancer cells while sparing normal cells (preclinical evidence only) • Potential pain relief properties - demonstrated antinociceptive effects in rat models through nitric oxide pathway modulation (animal studies only) • Possible [antiviral](/ingredients/condition/immune-support) activity - cnicin showed SARS-CoV-2 inhibition in vitro with IC50 of 1.18 µg/ml (laboratory evidence only) • Traditional digestive support - used historically for gastrointestinal disorders though no clinical trials exist • Potential antiparasitic effects - in silico and preclinical data suggest activity against parasites like Schistosoma (computer modeling and lab studies only) ## Mechanism of Action Cnicus benedictus exerts its effects primarily through nitric oxide pathway modulation, which contributes to its antinociceptive properties. The methanolic extract demonstrates selective antiproliferative activity against cancer cells while preserving normal cell viability. Bioactive compounds including cnicin and various flavonoids appear to be responsible for these targeted cellular effects. ## Clinical Summary Current evidence for Cnicus benedictus is limited to preclinical studies. In vitro research showed methanolic extracts inhibited HeLa cervical cancer cell proliferation while sparing normal cells, though specific inhibition percentages were not quantified. Animal studies in rat models demonstrated antinociceptive effects through nitric oxide pathway involvement. No human clinical trials have been conducted to validate these preliminary findings or establish effective dosages. ## Nutritional Profile Cnicus benedictus (blessed thistle) is a bitter herb with limited macronutrient significance as it is consumed in small medicinal quantities rather than as a food staple. Key bioactive compounds include: Sesquiterpene lactones - cnicin (primary bitter principle) at approximately 0.2-0.7% dry weight, the most pharmacologically active constituent; Polyacetylenes including tridecadienetetraynes; Flavonoids - luteolin, apigenin, astragalin, and kaempferol glycosides present at trace levels; Tannins (hydrolysable and condensed) at approximately 2-3% dry weight contributing astringency; Lignans including arctigenin and trachelogenin; Essential oil constituents (p-cymene, fenchone, citral) at <0.3% dry weight; Triterpenoids including alpha- and beta-amyrin; Organic acids including succinic acid and mucilage polysaccharides. Mineral content includes modest potassium, calcium, and magnesium. The herb contains trace amounts of vitamins but these are not nutritionally significant at typical dosages. Bioavailability note: Cnicin is relatively well-absorbed orally but undergoes hepatic [metabolism](/ingredients/condition/weight-management); bitter compounds stimulate digestive secretions, which may enhance absorption of co-ingested nutrients. Most bioactive compounds are better extracted in ethanol/water mixtures (50-70% ethanol) than in water alone. ## Dosage & Preparation No clinically studied human dosages exist. Animal studies used 150-300 mg/kg of methanolic extract or 30 mg/kg of isolated cnicin in rats. In vitro studies used 0.1-1,000 µg/ml concentrations. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Safety data for Cnicus benedictus supplementation is limited due to lack of human studies. As a member of the Asteraceae family, it may cause allergic reactions in individuals sensitive to plants like ragweed, chrysanthemums, or daisies. Potential interactions with nitric oxide-affecting medications or cancer treatments are unknown but theoretically possible. Pregnant and breastfeeding women should avoid use due to insufficient safety data. ## Scientific Research No human clinical trials, RCTs, or meta-analyses exist for Cnicus benedictus according to regulatory assessments. All available evidence comes from in vitro cell culture studies, animal models in rats, and computer simulations, with no PMIDs provided in the research dossier. ## Historical & Cultural Context Cnicus benedictus has centuries of use in European folk medicine and was documented by Avicenna in the Canon of Medicine for digestive issues, pain relief, and as a galactagogue. It has been traditionally employed as a bitter tonic herb across global traditional medicine systems. ## Synergistic Combinations Milk thistle, dandelion root, artichoke leaf, turmeric, ginger ## Frequently Asked Questions ### What is the active compound in Cnicus benedictus? The primary bioactive compound is cnicin, a sesquiterpene lactone, along with various flavonoids. These compounds are concentrated in methanolic extracts and appear responsible for the plant's antiproliferative and analgesic effects. ### How does Cnicus benedictus affect cancer cells? Preclinical studies show methanolic extracts selectively inhibit cancer cell growth, particularly in HeLa cervical cancer cells, while leaving normal cells unharmed. However, this evidence comes only from laboratory studies, not human trials. ### Can Cnicus benedictus help with pain relief? Animal studies suggest it may provide pain relief through nitric oxide pathway modulation, demonstrating antinociceptive effects in rat models. However, human studies are needed to confirm effectiveness and determine appropriate dosages. ### Is Cnicus benedictus safe to take with medications? Safety interactions are unknown due to limited research. It may theoretically interact with nitric oxide-affecting drugs or cancer treatments, so consultation with healthcare providers is essential before use. ### What's the recommended dosage for Cnicus benedictus? No standardized human dosage exists as clinical trials have not been conducted. All current evidence comes from preclinical studies using various extract concentrations, making dosage recommendations impossible without further research. ### What is the difference between Cnicus benedictus and milk thistle, and are they often confused? Cnicus benedictus (blessed thistle) and milk thistle (Silybum marianum) are distinct plants from the Asteraceae family, though both are thistles used in herbal medicine. While milk thistle is primarily known for liver support via silymarin, blessed thistle has been traditionally used for digestive and inflammatory concerns. They are sometimes confused due to similar names and family classification, but possess different phytochemical profiles and traditional applications. ### Is Cnicus benedictus safe to use during pregnancy and breastfeeding? Safety data for Cnicus benedictus during pregnancy and breastfeeding is limited, and it is generally recommended to avoid use in these populations without professional guidance. Historically, blessed thistle has been used to support lactation in some traditional practices, but clinical evidence is insufficient to confirm safety or efficacy. Pregnant and breastfeeding individuals should consult with a healthcare provider before supplementing. ### How strong is the current scientific evidence for Cnicus benedictus health benefits in humans? Most research on Cnicus benedictus remains at the preclinical stage, with promising in vitro and animal studies but very limited human clinical trials. The antiproliferative, antinociceptive, and antiviral findings come primarily from laboratory and rodent models, which do not reliably translate to human efficacy. Robust human-based clinical evidence is needed before definitive health claims can be made about this ingredient. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*